ClinicalTrials.Veeva

Menu

Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Shock
Hemorrhage

Treatments

Procedure: NovoSeven treatment according to guideline

Study type

Observational

Funder types

Other

Identifiers

NCT00192933
2004-41-3996

Details and patient eligibility

About

The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for NovoSeven treatment according to our guideline

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Jakob Stensballe, MD; Pär Johansson, MD, MPA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems